Prothena Biosciences Inc is a leading biotechnology company based in South San Francisco, CA, specializing in the development of novel therapies for neurodegenerative diseases such as AL Amyloidosis, Parkinson's Disease, ATTR Amyloidosis, and Alzheimer's Disease.
With a strong focus on scientific innovation and a robust pipeline of potential treatments, Prothena is dedicated to advancing the field of neurodegenerative disease research and improving the lives of patients worldwide.
Generated from the website